Back to Journals » Infection and Drug Resistance » Volume 17

Association Between Age and the 28-Day All-Cause Mortality in Tuberculosis Complicated by Sepsis in ICU Patients: A Retrospective Cohort Study

Authors Cui K , Mao Y, Feng S, Luo H, Yang J, Xu R, Bai L

Received 11 January 2024

Accepted for publication 30 April 2024

Published 10 May 2024 Volume 2024:17 Pages 1879—1892

DOI https://doi.org/10.2147/IDR.S455108

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Prof. Dr. Héctor Mora-Montes



Kunping Cui,1,* Yi Mao,2,* Shuang Feng,3 Haixia Luo,2 Jiao Yang,2 Ruyi Xu,1 Lang Bai1

1Center of Infectious Diseases, West China Hospital of Sichuan University, Chengdu, Sichuan, 610041, People’s Republic of China; 2Intensive Care Unit, Public Health Clinical Center of Chengdu, Chengdu, Sichuan, 610000, People’s Republic of China; 3Ultrasonic Medicine, Public Health Clinical Center of Chengdu, Chengdu, Sichuan, 610000, People’s Republic of China

*These authors contributed equally to this work

Correspondence: Lang Bai, Center of Infectious Diseases, West China Hospital of Sichuan University, Chengdu, Sichuan, 610041, People’s Republic of China, Tel +86-18980602254, Email [email protected]

Purpose: Age is considered a vital factor in intensive care units (ICUs) because of its association with physiological frailty, comorbidities, and immune system function. Previous studies have examined the association between age and prognosis in patients with tuberculosis (TB) or sepsis; however, the association between age and prognosis in ICU patients with TB complicated by sepsis is rare. This study aimed to assess the association between age and the prognosis of patients in the ICU with TB complicated by sepsis.
Patients and Methods: Data from the ICU of the Public Health Clinical Center of Chengdu were analyzed using the multivariable Cox regression model, stratified analysis with interaction, restricted cubic spline (RCS), and threshold effect analysis to investigate the association between age and 28-day all-cause mortality in patients with TB complicated by sepsis.
Results: In total, 520 patients diagnosed with TB and sepsis were enrolled (120 women [23.1%]; median age, 64 years). The association between age and risk of death exhibited a J-shaped curve on the RCS (P for nonlinearity = 0.001). In the threshold analysis, the hazard ratio for the risk of death was 1.104 (95% confidence interval, 1.05– 1.16) in participants aged ≥ 66.2 years. The risk of death increased by 10.4% with every 1-year increase in age in patients with TB complicated by sepsis. No significant association was found between age and 28-day all-cause mortality in patients aged < 66.2 years.
Conclusion: A nonlinear relationship was observed between age and short-term all-cause mortality in patients in the ICU with TB complicated by sepsis. Patients with a higher age at admission may have a higher risk of death and require focused attention, close monitoring, and early treatment to reduce mortality.

Keywords: sepsis, tuberculosis, age, 28-day all-cause mortality, intensive care unit

Introduction

Tuberculosis (TB) is a chronic infectious disease caused by Mycobacterium tuberculosis. The World Health Organization reported a total of 10.6 million new cases of TB and 1.3 million deaths worldwide in 2022, making it one of the leading infectious disease killers globally.1 Sepsis is a severe organ dysfunction caused by an inadequate or dysregulated response to infection.2 According to an analysis of the global burden of sepsis from 1990 to 2017,3 approximately 48.9 million cases of sepsis and 11 million deaths worldwide were documented in 2017. A meta-analysis based on modeling or prospective studies in 2023 reported that the annual incidence of sepsis worldwide was 276–678 per 100,000, with a fatality rate of 22.5–26.7%;4 however, the study data only represented some regions worldwide. Another epidemiological study on sepsis in China showed that the annual incidence of sepsis was approximately 421.85/100,000 in 2019, of which 57.5% occurred in individuals aged >65 years and the hospital fatality rate was approximately 30%.5 TB complicated by sepsis involves chronic and acute infections, contributing to the increased complexity of the condition and resulting in an unfavorable prognosis. Therefore, exploring the factors related to the prognosis in this patient group is of paramount importance.

Rapidly aging populations pose a huge challenge to the global allocation of limited health care resources. Age is a crucial indicator of immune function and physiology. With increasing age, the immune system undergoes a series of changes, including a decline in the immune response, alterations in the inflammatory response, and a decrease in disease tolerance,6 leading to significant differences in clinical manifestations and therapeutic outcomes in patients of different ages. An increasing number of studies have focused on the changes in organ function, increased frailty, and decreased activities of daily living in older patients that lead to increased intensive care unit (ICU) admissions and mortality.7,8 Several studies have shown that older patients are at an increased risk of developing active TB due to waning immunity and combined chronic diseases.9,10 They may exhibit atypical symptoms, delayed diagnosis, and experience more severe forms of the disease. It is well known that advanced age is a risk factor for developing sepsis, and older adults are more prone to severe sepsis and have a higher mortality rate compared to younger patients.5,11 However, few studies have assessed the association between age and prognosis in patients admitted to the ICU with sepsis-complicated TB. This study aimed to investigate whether age is independently associated with 28-day all-cause mortality in patients admitted to the ICU with TB complicated by sepsis. This exploration is crucial for a more comprehensive assessment of patient prognosis and development of strategies for graded management.

Materials and Methods

Study Design and Participants

This retrospective single-center analysis used the data of consecutive patients who were diagnosed with TB complicated by sepsis in the ICU at the Public Health Clinical Center of Chengdu (Sichuan Province, China, between January 1, 2019, and February 1, 2023. This study was conducted in accordance with the principles of the Declaration of Helsinki (revised in Brazil, 2013) and was approved by the Ethics Review Board of the Public Health Clinical Center of Chengdu (YJ-K2022-16-01). Due to the retrospective nature of the study, no intervention was involved, anonymous patient data were used, and the requirement for obtaining informed consent was waived. This study was conducted following the Strengthening the Reporting of Observational Studies in Epidemiology guidelines.12

TB was diagnosed using the International Classification of Disease, Tenth Revision (ICD-10),13 based on the results of etiological (including bacteriology and molecular biology) examination, epidemiological history, clinical manifestations, imaging findings, auxiliary examination results, and differential diagnosis; a comprehensive analysis was used for diagnosis.14 Sepsis was defined as an infection combined with evidence of organ dysfunction based on the third international consensus definition.2 Additionally, ICD-10 criteria were used to diagnose the infection. Organ dysfunction was characterized by an increased sequential organ failure assessment (SOFA) score of ≥2 points.13,15 The baseline SOFA score of all patients in the ICU was presumed to be 0.16 In addition, the diagnoses and treatments of all patients admitted to the ICU were discussed by at least two critical care physicians.

Upon admission to the ICU, all participants underwent a comprehensive assessment and standardized medical history data collection, including physical and laboratory examinations, and collection of demographic and health-related data. In cases in which a patient’s critical condition impeded the direct acquisition of standardized medical history data, information was obtained from immediate family members.

Inclusion and Exclusion Criteria

Patients who, (1) required special monitoring and treatment in the ICU, (2) met the diagnostic criteria for TB complicated by sepsis, (3) were aged between 18 and 80 years, and (4) were admitted to the ICU for at least 24 h, were selected. Pregnant women, patients with tumors, and patients with HIV infections were excluded. The inclusion and exclusion criteria are shown in Figure 1.

Figure 1 Flow chart of participants included in this analysis.

Data Collection

The data used in this study were extracted from the hospital’s electronic information management system. First, the population included in the study was determined based on the inclusion and exclusion criteria. The demographic information of the patients was extracted, and an Excel database was established.

Demographic information included age, gender, race, smoking status, alcohol use, body mass index (BMI), and severity at admission as measured by the Acute Physiology and Chronic Health Evaluation (APACHE) II and SOFA scores. We categorized the participants into two races: Han Chinese and others (including Tibetans and Yis).

Previous studies have confirmed that age, BMI, hypertension, diabetes, intra-abdominal infection, hypotension, and lactate and hemoglobin (HGB) levels are prognostic risk factors for TB or sepsis.17–19 To further investigate the association between age and risk of 28-day all-cause mortality in patients admitted to the ICU with TB complicated by sepsis, our study also included indicators such as immunosuppressive therapy, drug-resistant tuberculosis, primary site of infection (intra-abdominal infection and urinary tract infection), primary site of tuberculosis infection (pulmonary tuberculosis, tuberculous meningitis [TBM], intra-abdominal tuberculosis, urinary system tuberculosis, and tuberculosis in other parts of the body), comorbidities (chronic obstructive pulmonary disease [COPD], chronic kidney disease [CKD], chronic liver disease, systemic lupus erythematosus [SLE], rheumatoid arthritis [RA], and pneumothorax), vital signs (temperature, heart rate, respiratory rate, and mean arterial pressure [MAP]), laboratory test indicators (including count of white blood cells [WBC], red blood cells, and platelets, platelet count [PLT], and levels of HGB, procalcitonin level, C-reactive protein, and lactate), and interventions (invasive mechanical ventilation and vasopressor use). Based on the small number of patients with bone, laryngeal, skin, and genital tuberculosis in our study, we collected them into one group named tuberculosis in other parts of the body.

Demographic characteristics and vital signs were obtained at the time of ICU admission, and comorbidities were primarily identified through patient self-reports or previous diagnoses. Laboratory tests were performed using blood samples collected within 24 h of admission to the ICU. APACHE II and SOFA scores were obtained within 24 h of ICU admission. Patients were considered to have an intervention (invasive mechanical ventilation, vasopressor use) if it occurred within 24 h of admission to the ICU.

Outcome

The primary outcome of this study was the 28-day all-cause mortality from the day of ICU admission. Due to the retrospective nature of this study, endpoint events were determined by collecting patient information.

Statistical Analysis

This study aimed to determine the association between age and 28-day all-cause mortality in patients with TB complicated by sepsis. To gain a more detailed understanding of the characteristics of the study population at different ages, the patients were divided into four groups based on age quantiles, rather than the unevenly distributed tertiles, and a descriptive analysis was performed (Supplementary Table 1). Continuous data with a skewed distribution were expressed as medians and interquartile ranges. Categorical variables were expressed as proportions (%). Baseline characteristics across age quartile groups were compared using one-way analysis of variance for continuous variables and Pearson’s chi-square test or Fisher’s exact test for categorical variables. Survival curves for different age groups were plotted using the Kaplan–Meier method and compared statistically using the Log rank test.

Cox hazard regression models were used to determine the hazard ratios (HR) and 95% confidence intervals (95% CIs) for the relationship between age and 28 d mortality. Model I was unadjusted. Model II was adjusted for gender and comorbidities (hypertension, diabetes mellitus, COPD, chronic liver disease, SLE, RA, and pneumothorax). Model III was adjusted for model II plus drug-resistant tuberculosis, primary site of infection (intra-abdominal and urinary tract infections), and primary site of tuberculosis infection (pulmonary tuberculosis, TBM, intra-abdominal tuberculosis, urinary system tuberculosis, and tuberculosis in other parts of the body). In model IV, we selected these covariables based on their association with the outcomes of interest or a change-in-effect estimate >10%, which included BMI, hypertension, COPD, heart rate, mechanical ventilation, and vasopressor use (Supplementary Table 2).20 Model V was adjusted for gender and the variables with P values <0.05 in the univariate Cox regression model (including immunosuppressive therapy, BMI, intra-abdominal infection, urinary tract infection, hypertension, diabetes, CKD, temperature, heart rate, MAP, HGB and lactate levels, PLT count, mechanical ventilation, and vasopressor use) (Supplementary Table 3).21

In addition, RCS regression was performed with four knots at the 5th, 35th, 65th, and 95th percentiles of age to assess linearity and examine the dose-response curve between age and 28-day all-cause mortality in TB complicated by sepsis after adjusting for the variables in model V.

 If the relationship was nonlinear, we used a two-piecewise Cox regression model with smoothing to analyze the association threshold between age and 28-day all-cause mortality after adjusting for the variables in Model V. The likelihood-ratio test and bootstrap resampling method were used to determine inflection points.

Furthermore, potential modifications to the relationship between age and 28 d mortality were assessed, including gender, immunosuppressive therapy, drug-resistant tuberculosis, hypertension, diabetes, COPD, CKD, pneumothorax, mechanical ventilation, and vasopressor use. Heterogeneity among the subgroups was assessed using multivariate Cox hazard regression, and interactions between the subgroups and age were examined using likelihood ratio testing.

All analyses were performed using R Statistical Software (version 4.2.2, http://www.R-project.org) and the Free Statistics analysis platform (Version 1.8). A two-tailed test was performed, and a P value of <0.05 was considered significant.

Results

Patient Selection

Six hundred and twenty-five patients with TB who developed sepsis were identified according to the third international consensus definition. After screening based on the inclusion and exclusion criteria, the final cohort included 520 patients. A flowchart of the patient selection process is shown in Figure 1.

Patient Baseline Characteristics

The baseline patient characteristics are presented in Table 1. The enrolled patients were divided into four groups by the quartiles of age: Q1 group, 18–48 years; Q2 group, 49–63 years; Q3 group, 64–72 years; and Q4 group, 73–80 years. The median age of all participants was 64.0 (49.0, 73.0) years, and 23.1% were female. Participants with a higher age were more likely to have higher APACHE II scores, higher mortality, male, Han Chinese ethnicity, alcohol use, hypertension, diabetes, and COPD, be smokers, and were less likely to have drug-resistant tuberculosis and chronic liver disease compared with participants in the lowest age quartile. Additionally, significant differences in other indicators were observed between the groups, with participants in the highest age quartile having a lower temperature, heart and respiratory rates, WBC and PLT counts, and HGB level than those in the lowest age quartile.

Table 1 Baseline Characteristics of the Study Participants by Age Quartiles

Outcomes

The overall 28-day all-cause mortality rate was 46.3%. The 28-day all-cause mortality rates of patients in the lowest to highest age quartile (18–48, 49–63, 64–72, and 73–80) were 40.3, 41.4, 39.2, and 63.9%, respectively (Table 1). Kaplan–Meier curves showed that patients in the higher age quartile had a higher risk of 28-day all-cause mortality (Log rank test, P <0.0001, Figure 2).

Figure 2 Kaplan-Meier survival curve for 28-day mortality of tuberculosis complicated by sepsis in different age groups.

Notes: Log rank X2 = 26.43, df = 3, P < 0.001.

Association between age and 28-day all-cause mortality

We constructed five multivariate Cox regression models to investigate the independent association between age and mortality risk in patients with TB complicated by sepsis (Table 2). In model I, which was not adjusted for covariables, age was positively associated with 28-day all-cause mortality (HR, 1.016; 95% CI, 1.007–1.024). Even after adjusting for various covariates in models II–V, mortality still increased by 1.2–1.8% for every 1-year increase in age (Table 2).

Table 2 Association Between Age and the 28-Day All-Cause Mortality in Tuberculosis Complicated by Sepsis ICU Patients

When age was entered as a categorical variable in each adjusted model, the changing trend of the effective value in different age groups was non-equidistant. After adjusting for gender, immunosuppressive therapy, BMI, intra-abdominal infection, urinary tract infection, hypertension, diabetes, CKD, temperature, heart rate, MAP, HGB and lactate levels, PLT count, invasive mechanical ventilation, and vasopressor use in model V, the multivariate-adjusted HR and 95% CI from lowest to highest age quartile (18–48, 49–63, 64–72, and 73–80) were 1.00 (reference), 0.97 (0.64, 1.46), 0.99 (0.64, 1.55), and 1.83 (1.21, 2.77), respectively, for the risk of 28-day all-cause mortality (P = 0.001) (Table 2).

Dose-Response Relationship Between Age and Mortality

As a previous multivariate Cox regression analysis indicated a nonlinear relationship between baseline age and the risk of 28-day all-cause mortality in patients with TB complicated by sepsis, we employed a Cox proportional hazards regression model with RCS analysis to further investigate the correlation. Multivariate-adjusted RCS analyses suggested J-shaped associations between age and 28-day all-cause mortality in patients with TB complicated by sepsis (P for nonlinearity = 0.001, Figure 3). Similarly, the unadjusted RCS analysis yielded consistent results (nonlinear P < 0.001, Figure 5). Based on the threshold effect analysis, we identified the inflection age for the 28-day all-cause mortality as 66.2 years (Table 3). Beyond this threshold, the 28-day all-cause mortality demonstrated a rapid increase with a multivariable adjusted HR of 1.104 (95% CI, 1.05–1.16; Table 3); below this threshold, the estimated dose-response curve remained consistent with a approximately horizontal line with a multivariable adjusted HR of 0.996 (95% CI, 0.980–1.012; Table 3). This finding suggests that the 28-day all-cause mortality risk increased by 10.4% every year after the age of 66.2 years. However, the risk of mortality did not increase with advancing age when age was <66.2 years.

Table 3 Threshold Effect Analysis of the Association of Age and the 28-Day All-Cause Mortality in Tuberculosis with Sepsis ICU Patients

Figure 3 The nonlinear relationship of age and the risk of 28-day mortality fit by Cox proportional hazards regression models with multivariate-adjusted RCS analyses.

Notes: Solid and dashed lines represent the predicted value and 95% confidence intervals. It was adjusted for gender, immunosuppressive therapy, BMI, intra-abdominal infection, urinary tract infection, hypertension, diabetes, CKD, temperature, heart rate, MAP, HGB, PLT, lactate, invasive mechanical ventilation use, and vasopressor use. All of the data was displayed.

Subgroup Analysis

The results of the subgroup analyses are shown in Figure 4. Except for COPD, no significant interactions were observed in the subgroups (P = 0.023). Additional factors associated with mortality in patients with TB and sepsis admitted to the ICU included gender, immunosuppressive therapy, drug resistant tuberculosis, hypertension, diabetes, COPD, CKD, pneumothorax, invasive mechanical ventilation, and vasopressor use (Figure 4).

Figure 4 The relationship between age and the 28-day all-cause mortality in the subgroup analysis based on the tuberculosis complicated by sepsis ICU patients.

Abbreviations: HR, hazard ratio; CI, confidence interval; COPD, chronic obstructive pulmonary disease; CKD, chronic kidney disease.

Notes: Each stratification was adjusted for gender, immunosuppressive therapy, BMI, intra-abdominal infection, urinary tract infection, hypertension, diabetes, CKD, temperature, heart rate, MAP, HGB, PLT, lactate, invasive mechanical ventilation use, and vasopressor use; Diamonds indicate odds ratios (ORs), with horizontal lines indicating 95%.

Figure 5 The nonlinear relationship of age and the risk of 28-day mortality fit by Cox proportional hazards regression models with unadjusted RCS analyses.

Notes: Solid and dashed lines represent the predicted value and 95% confidence intervals. It was adjusted for model I. All of the data was displayed.

Discussion

In this retrospective cohort study, we observed a J-shaped association between age and 28-day all-cause mortality in patients diagnosed with sepsis-complicated tuberculosis. The subgroup analysis indicated that the age-related risk of mortality was higher among patients with hypertension, COPD, CKD, and pneumothorax. We confirmed by threshold analysis that the age-related risk of mortality was 1.093 in participants aged ≥66.2 years, whereas there was no significant association between age and the risk of mortality when the age was <66.2 years.

It is well established that advanced age is a prominent risk factor for COPD, hypertension, diabetes, and CKD.22 Similarly, in our study, hypertension, diabetes, and COPD were mainly distributed among older people, but no similar distribution trend was observed for CKD or chronic liver disease, which may be related to the small sample size of our study population. When exploring the relationship between the age of patients with TB complicated by sepsis and chronic comorbidities, we observed a significant interaction in the COPD subgroup, which may have modified the impact of age on mortality. This may be due to the fact that patients with COPD usually have age-related factors such as decreased immunity, airway inflammation, and an abnormal immune response.23,24 This condition accelerates the progression of COPD,25 TB,26 and sepsis27 when combined with other infections. However, the underlying pathophysiological mechanisms must be confirmed in further studies.

The nonlinear association between age and adverse prognosis extends across various diseases. Xie et al reported a U-shaped association between age and the prognosis of breast cancer in women.28 Zhang et al reported a J-shaped association between maternal age and spontaneous abortion.29 Thompson et al reported a J- or U-shaped association between parental age, neonatal morbidity, and mortality.30 Similarly, our study confirmed a J-shaped association between age and mortality, which could support the hierarchical management of patients.

Previous clinical studies have confirmed that age is an important factor in the prognosis of TB and sepsis.31,32 Similarly, our study found that older patients with TB complicated by sepsis had the highest mortality rate among the groups, and the risk of death increased with age after age ≥66.2 years. This result confirms that the older population is at high risk for death among patients with TB complicated by sepsis and require significant attention. Medical resources are very limited, and to reduce mortality in TB complicated by sepsis, it is necessary for older patients to take active and effective measures. First, early and close monitoring, timely intervention, and treatment in the case of disease changes. Second, a comprehensive assessment of physical status and disease was conducted to formulate a scientific treatment plan, and professional nursing care and rehabilitation exercises were provided to promote psychological and physical recovery.

This study had some limitations. First, as in all observational studies, potentially uncontrolled confounding factors may exist. Despite efforts to adjust for covariates and substantiate the robust association between age and 28-day all-cause mortality, validation through a large-sample study is warranted. Second, our study was retrospective and the parameters included in the study were tested only at baseline, which may vary with disease changes. Residual or unmeasured confounding factors or some of the factors that affect the prognosis of TB or sepsis that were not included may have impacted the study. This may have weakened our results. We will include more parameters related to patient prognosis and conduct a prospective study to validate our results. Finally, our study population was derived exclusively from Western China, which introduced an inevitable selection bias. The results of this study should be further verified through multicenter trials.

Conclusions

This study revealed a nonlinear relationship between age and short-term all-cause mortality in patients admitted to the ICU with sepsis-complicated TB. Age is an important prognostic factor in older patients. Stratified management of TB complicated by sepsis according to age, with a focus on older patients for whom close monitoring and early treatment could reduce mortality rates, is appropriate.

Data Sharing Statement

The data supporting the findings of this study are available from the first author, Kunping Cui, upon reasonable request.

Acknowledgments

We thank Dr. Jie Liu (Department of Vascular and Endovascular Surgery, Chinese PLA General Hospital) for his help with statistical analysis. We wish to thank all the patients who participated in this study.

Author Contributions

All authors made a significant contribution to the work reported, whether that is in the conception, study design, execution, acquisition of data, analysis and interpretation, or in all these areas; took part in drafting, revising or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work.

Funding

Sichuan Provincial Science and Technology Plan Project (2023YFSY0043).

Disclosure

The authors declare that this study was conducted in the absence of any commercial or financial associations that could be construed as potential conflicts of interest.

References

1. World Health Organization. Global tuberculosis report 2023. Geneva, Switzerland: World Health Organization; 2023. Available from: https://www.who.int/teams/global-tuberculosis-programme/tb-reports. Accessed May 03, 2024.

2. Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801–810.PMID: 26903338; PMCID: PMC4968574. doi:10.1001/jama.2016.0287

3. Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study. Lancet. 2020;395(10219):200–211.PMID: 31954465; PMCID: PMC6970225. doi:10.1016/S0140-6736(19)32989-7

4. Fleischmann-Struzek C, Rudd K. Challenges of assessing the burden of sepsis. Med Klin Intensivmed Notfmed. 2023;118:68–74. English. PMID: 37975898. doi:10.1007/s00063-023-01088-7

5. Weng L, Xu Y, Yin P, et al.; China Critical Care Clinical Trials Group (CCCCTG). National incidence and mortality of hospitalized sepsis in China. Crit Care. 2023;27(1):84. PMID: 36870989; PMCID: PMC9985297. doi:10.1186/s13054-023-04385-x

6. Maggini S, Pierre A, Calder PC. Immune function and micronutrient requirements change over the life course. Nutrients. 2018;10(10):1531. PMID: 30336639; PMCID: PMC6212925. doi:10.3390/nu10101531

7. Vincent JL, Creteur J. Appropriate care for the elderly in the ICU. J Intern Med. 2022;291(4):458–468. PMID: 34487587. doi:10.1111/joim.13371

8. Andre V, Aissaoui N, Vincent F. ICU admission and mortality among elderly adults. JAMA. 2018;319(10):1047. PMID: 29536090. doi:10.1001/jama.2017.21668

9. Kobayashi N, Tanaka K, Muraoka S, et al. Influence of age, IGRA results, and inflammatory markers on mortality in hospitalized tuberculosis patients. J Infect Chemother. 2024;30(1):48–52.PMID: 37704163. doi:10.1016/j.jiac.2023.09.011

10. Xie Y, Han J, Yu W, et al. Survival analysis of risk factors for mortality in a cohort of patients with tuberculosis. Can Respir J. 2020;2020:1654653. PMID: 32963642; PMCID: PMC7492936. doi:10.1155/2020/1654653

11. Mankowski RT, Anton SD, Ghita GL, et al. Older adults demonstrate biomarker evidence of the persistent inflammation, immunosuppression, and catabolism syndrome (PICS) after sepsis. J Gerontol a Biol Sci Med Sci. 2022;77(1):188–196.PMID: 33721883; PMCID: PMC8751807. doi:10.1093/gerona/glab080

12. Vandenbroucke JP, von Elm E, Altman DG, et al. STROBE Initiative. Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. PLoS Med. 2007;4(10):e297.PMID: 17941715; PMCID: PMC2020496. doi:10.1371/journal.pmed.0040297

13. Reeves SL, Freed GL. Problems with quality measurement using international statistical classification of diseases, tenth revision, clinical modification: the elephant no one knows is in the room. JAMA Pediatr. 2019;173(6):515–516. PMID: 31034035; PMCID: PMC7059548. doi:10.1001/jamapediatrics.2019.0844

14. Suárez I, Fünger SM, Kröger S, Rademacher J, Fätkenheuer G, Rybniker J. The Diagnosis and Treatment of Tuberculosis. Dtsch Arztebl Int. 2019;116(43):729–735. PMID: 31755407. doi:10.3238/arztebl.2019.0729

15. Cecconi M, Evans L, Levy M, Rhodes A. Sepsis and septic shock. Lancet. 2018;392(10141):75–87. PMID: 29937192. doi:10.1016/S0140-6736(18)30696-2

16. Komorowski M, Celi LA, Badawi O, Gordon AC, Faisal AA. The Artificial Intelligence Clinician learns optimal treatment strategies for sepsis in intensive care. Nat Med. 2018;24(11):1716–1720. PMID: 30349085. doi:10.1038/s41591-018-0213-5

17. Bhargava A, Bhargava M, Meher A, et al. Nutritional support for adult patients with microbiologically confirmed pulmonary tuberculosis: outcomes in a programmatic cohort nested within the RATIONS trial in Jharkhand, India. Lancet Glob Health. 2023;11(9):e1402–e1411.PMID: 37567210. doi:10.1016/S2214-109X(23)00324-8

18. Romanowski K, Baumann B, Basham CA, et al. Long-term all-cause mortality in people treated for tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis. 2019;19(10):1129–1137.PMID: 31324519. doi:10.1016/S1473-3099(19)30309-3

19. Qu Z, Zhu Y, Wang M, et al. Prognosis and risk factors of sepsis patients in Chinese icus: a retrospective analysis of a cohort database. Shock. 2021;56(6):921–926.PMID: 33843790; PMCID: PMC8579969. doi:10.1097/SHK.0000000000001784

20. Qu X, Yang H, Yu Z, et al. Serum zinc levels and multiple health outcomes: implications for zinc-based biomaterials. Bioact Mater. 2020;5(2):410–422.PMID: 32258830; PMCID: PMC7114479. doi:10.1016/j.bioactmat.2020.03.006

21. Agoritsas T, Merglen A, Shah ND, O’Donnell M, Guyatt GH. Adjusted analyses in studies addressing therapy and harm: users’ guides to the medical literature. JAMA. 2017;317(7):748–759. PMID: 28241362. doi:10.1001/jama.2016.20029

22. Chen X, Giles J, Yao Y, et al. The path to healthy ageing in China: a Peking University-lancet commission. Lancet. 2022;400(10367):1967–2006.PMID: 36423650; PMCID: PMC9801271. doi:10.1016/S0140-6736(22)01546-X

23. Christenson SA, Smith BM, Bafadhel M, Putcha N. Chronic obstructive pulmonary disease. Lancet. 2022;399(10342):2227–2242. PMID: 35533707. doi:10.1016/S0140-6736(22)00470-6

24. Cho WK, Lee CG, Kim LK. COPD as a Disease of Immunosenescence. Yonsei Med J. 2019;60(5):407–413. PMID: 31016901; PMCID: PMC6479124. doi:10.3349/ymj.2019.60.5.407

25. Maselli DJ, Bhatt SP, Anzueto A, et al. Clinical Epidemiology of COPD: insights from 10 years of the COPD gene study. Chest. 2019;156(2):228–238.PMID: 31154041; PMCID: PMC7198872. doi:10.1016/j.chest.2019.04.135

26. Korzeniewska-Koseła M. Tuberculosis in Poland in 2018. Przegl Epidemiol. 2020;74(2):239–257. PMID: 33112107. doi:10.32394/pe.74.19

27. Cui Z, Wang L, Li H, Feng M. Study on immune status alterations in patients with sepsis. Int Immunopharmacol. 2023;118:110048. PMID: 36989895. doi:10.1016/j.intimp.2023.110048

28. Xie Y, Deng Y, Wei S, et al. Age has a U-shaped association with breast cancer outcomes in women: a cohort study. Front Oncol. 2023;13:1265304. PMID: 37860197; PMCID: PMC10583555. doi:10.3389/fonc.2023.1265304

29. Zhang M, Yang BY, Sun Y, et al. nonlinear association of maternal age with risk of spontaneous abortion: a case-control study in the china birth cohort. Front Public Health. 2022;10:933654. PMID: 35910867; PMCID: PMC9330030. doi:10.3389/fpubh.2022.933654

30. Thompson JA. The risks of advancing parental age on neonatal morbidity and mortality are U- or J-shaped for both maternal and paternal ages. BMC Pediatr. 2020;20(1):453. PMID: 32988379; PMCID: PMC7520964. doi:10.1186/s12887-020-02341-0

31. Khalife S, Jenkins HE, Dolynska M, et al. Incidence and mortality of extrapulmonary tuberculosis in Ukraine: analysis of national surveillance data. Clin Infect Dis. 2022;75(4):604–612.PMID: 34929028; PMCID: PMC9464074. doi:10.1093/cid/ciab1018

32. Ko RE, Kang D, Cho J, et al.; Korean Sepsis Alliance (KSA) investigators. Influence of sex on age-associated in-hospital mortality in patients with sepsis and septic shock: a prospective nationwide multicenter cohort study. Crit Care. 2023;27(1):229. PMID: 37303037; PMCID: PMC10257805. doi:10.1186/s13054-023-04515-5

Creative Commons License © 2024 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.